bezafibrate has been researched along with atenolol in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 5 (50.00) | 24.3611 |
| 2020's | 2 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chuang, S; Horne, J; Porter, CJ; Scanlon, MJ; Velkov, T | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Eagles, CJ; Kendall, MJ | 1 |
| Clerici, M; Luciani, F; Orlandi, C; Pomati, F; Zuccato, E | 1 |
| Bracale, M; Bruno, A; De Mattia, F; Labra, M; Marsoni, M; Vannini, C | 1 |
| Ding, T; Li, J; Wang, S; Yang, B | 1 |
| Gao, Z; Lin, H; Lin, W; Liu, A; Ping, S; Ren, Y | 1 |
1 trial(s) available for bezafibrate and atenolol
| Article | Year |
|---|---|
The effects of combined treatment with beta 1-selective receptor antagonists and lipid-lowering drugs on fat metabolism and measures of fatigue during moderate intensity exercise: a placebo-controlled study in healthy subjects.
Topics: Adrenergic beta-Antagonists; Adult; Ammonia; Analysis of Variance; Anticholesteremic Agents; Atenolol; Bezafibrate; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Energy Metabolism; Exercise; Fatigue; Fatty Acids, Monounsaturated; Fatty Acids, Nonesterified; Female; Fluvastatin; Heart Rate; Humans; Hypolipidemic Agents; Indoles; Lactic Acid; Lipids; Male; Oxygen Consumption; Triglycerides | 1997 |
9 other study(ies) available for bezafibrate and atenolol
| Article | Year |
|---|---|
Characterization of the drug binding specificity of rat liver fatty acid binding protein.
Topics: Anilino Naphthalenesulfonates; Animals; Fatty Acid-Binding Proteins; Ligands; Magnetic Resonance Spectroscopy; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Protein Binding; Rats; Spectrometry, Fluorescence; Substrate Specificity | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Effects and interactions in an environmentally relevant mixture of pharmaceuticals.
Topics: Atenolol; Bezafibrate; Cell Line; Cell Line, Tumor; Cell Proliferation; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Interactions; Escherichia coli; Humans; Lincomycin; Reproducibility of Results; Research Design; Risk Assessment; Toxicity Tests; Water Pollutants, Chemical | 2008 |
Uptake and effects of a mixture of widely used therapeutic drugs in Eruca sativa L. and Zea mays L. plants.
Topics: Albuterol; Atenolol; Bezafibrate; Brassicaceae; Carbamazepine; Cyclophosphamide; Drug Interactions; Germination; Humans; Lincomycin; Ofloxacin; Pharmaceutical Preparations; Ranitidine; Rivers; Tandem Mass Spectrometry; Wastewater; Water Pollutants, Chemical; Zea mays | 2014 |
Biological removal of pharmaceuticals by Navicula sp. and biotransformation of bezafibrate.
Topics: Atenolol; Bezafibrate; Biodegradation, Environmental; Carbamazepine; Diatoms; Fresh Water; Ibuprofen; Inactivation, Metabolic; Naproxen; Pharmaceutical Preparations; Sulfamethoxazole; Water Pollutants, Chemical | 2020 |
Ultraviolet photolysis of four typical cardiovascular drugs: mechanisms, influencing factors, degradation pathways, and toxicity trends.
Topics: Atenolol; Atorvastatin; Bezafibrate; Cardiovascular Agents; Humic Substances; Kinetics; Metoprolol; Photolysis; Ultraviolet Rays; Water Pollutants, Chemical | 2021 |